Product analysis
Extra Strength Hawthorn Extract 600 mg offers a low-cost, single-herb option for people considering heart support. The preparation cannot be assumed equivalent to the particular extracts behind the limited heart-related findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The named hawthorn marker helps identify the extract description. Comparative preparation quality remains uncertain, so it should not be equated with a particular clinical extract.
Ingredient Transparency100
The amount and extract description are stated, making basic comparisons easier. There is no mixed active blend obscuring its identity.
Value For Money100
The labeled serving cost compares favorably. That affordability is separate from whether the extract matches a preparation with supported benefits.
Customer Satisfaction87
Customer ratings are very positive across a large body of feedback. They describe satisfaction rather than establishing health benefits.
Product Focus73
A single herb keeps the purpose centered on heart-related support. The findings for particular extracts and clinical settings do not establish routine benefits from generic hawthorn.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $0.18
- Also available
Hawthorn Extract 300 mg$4.00- Customer rating
- 4.8 · 2,579 ratings
Goals
Hawthorn’s cardiovascular research mainly concerns specific extracts used in treated heart failure. A large trial did not improve its primary cardiac-event outcome, and generic hawthorn cannot inherit the tested extract’s findings. The declared amount therefore does not establish routine cardiovascular benefit or identify the studied preparation.
How this product is rated for Cardiovascular Support
Ingredient fit97
Goal fit
Dose adequacy
Pathways55
Depth
Breadth
Evidence81
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Hawthorn has been studied mainly as specific standardized extracts in clinical heart failure, with conflicting findings. Those results do not establish benefit for this ordinary hawthorn preparation or routine cardiovascular prevention. Its declared amount was recognized in the saved findings, but amount alone cannot resolve the difference in preparation and population.
How this product is rated for Heart Health
Ingredient fit97
Goal fit
Dose adequacy
Pathways41
Depth
Breadth
Evidence66
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn extract (Vitexin-2”-O-Rhamnoside) | 600 mg |
How this ingredient is rated
Composition and Label Disclosure57
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.